vs
徕博科（LH）与RENAISSANCERE HOLDINGS LTD（RNR）财务数据对比。点击上方公司名可切换其他公司
徕博科的季度营收约是RENAISSANCERE HOLDINGS LTD的1.6倍（$3.5B vs $2.2B），RENAISSANCERE HOLDINGS LTD净利率更高（23.5% vs 7.9%，领先15.6%），徕博科同比增速更快（5.8% vs -36.8%），过去两年徕博科的营收复合增速更高（4.8% vs -11.9%）
徕博科（Labcorp）是全球领先的生命科学与诊断检测企业，面向医疗机构、制药企业和个人患者提供全面的临床检验服务、药物研发支持及医疗检测解决方案，依托先进科研经验与创新技术输出准确可落地的健康洞察，助力临床决策、加快新药研发，提升全球患者健康水平。
RenaissanceRe Holdings Ltd是总部位于百慕大的保险及相关商业服务提供商，核心业务覆盖再保险、常规保险两大板块，同时运营风险相关创新投资业务，为全球客户提供专业的风险对冲与保险解决方案。
LH vs RNR — 直观对比
营收规模更大
LH
是对方的1.6倍
$2.2B
营收增速更快
LH
高出42.5%
-36.8%
净利率更高
RNR
高出15.6%
7.9%
两年增速更快
LH
近两年复合增速
-11.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.5B | $2.2B |
| 净利润 | $277.8M | $515.8M |
| 毛利率 | 28.7% | — |
| 营业利润率 | 10.8% | — |
| 净利率 | 7.9% | 23.5% |
| 营收同比 | 5.8% | -36.8% |
| 净利润同比 | 30.5% | 72.6% |
| 每股收益（稀释后） | $3.35 | $6.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LHRNR
| Q1 26 | $3.5B | $2.2B | ||
| Q4 25 | $3.5B | $3.0B | ||
| Q3 25 | $3.6B | $3.2B | ||
| Q2 25 | $3.5B | $3.2B | ||
| Q1 25 | $3.3B | $3.5B | ||
| Q4 24 | $3.3B | $2.3B | ||
| Q3 24 | $3.3B | $4.0B | ||
| Q2 24 | $3.2B | $2.8B |
净利润LHRNR
| Q1 26 | $277.8M | $515.8M | ||
| Q4 25 | $164.7M | $760.5M | ||
| Q3 25 | $261.1M | $916.5M | ||
| Q2 25 | $237.9M | $835.4M | ||
| Q1 25 | $212.8M | $170.0M | ||
| Q4 24 | $143.4M | $-189.7M | ||
| Q3 24 | $169.3M | $1.2B | ||
| Q2 24 | $205.3M | $503.9M |
毛利率LHRNR
| Q1 26 | 28.7% | — | ||
| Q4 25 | 28.2% | — | ||
| Q3 25 | 28.8% | — | ||
| Q2 25 | 29.7% | — | ||
| Q1 25 | 28.3% | — | ||
| Q4 24 | 26.9% | — | ||
| Q3 24 | 27.6% | — | ||
| Q2 24 | 28.8% | — |
营业利润率LHRNR
| Q1 26 | 10.8% | — | ||
| Q4 25 | 7.6% | 42.5% | ||
| Q3 25 | 11.1% | 46.3% | ||
| Q2 25 | 11.2% | 41.8% | ||
| Q1 25 | 9.7% | -2.0% | ||
| Q4 24 | 6.5% | -3.6% | ||
| Q3 24 | 7.7% | 43.7% | ||
| Q2 24 | 9.2% | 25.0% |
净利率LHRNR
| Q1 26 | 7.9% | 23.5% | ||
| Q4 25 | 4.7% | 25.6% | ||
| Q3 25 | 7.3% | 28.7% | ||
| Q2 25 | 6.7% | 26.1% | ||
| Q1 25 | 6.4% | 4.9% | ||
| Q4 24 | 4.3% | -8.3% | ||
| Q3 24 | 5.2% | 29.8% | ||
| Q2 24 | 6.4% | 17.8% |
每股收益（稀释后）LHRNR
| Q1 26 | $3.35 | $6.57 | ||
| Q4 25 | $1.98 | $16.16 | ||
| Q3 25 | $3.12 | $19.40 | ||
| Q2 25 | $2.84 | $17.20 | ||
| Q1 25 | $2.52 | $3.27 | ||
| Q4 24 | $1.72 | $-3.76 | ||
| Q3 24 | $2.00 | $22.62 | ||
| Q2 24 | $2.43 | $9.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $981.1M | $1.6B |
| 总债务越低越好 | $5.8B | — |
| 股东权益账面价值 | $8.7B | $4.3B |
| 总资产 | $19.1B | $53.7B |
| 负债/权益比越低杠杆越低 | 0.67× | — |
8季度趋势，按日历期对齐
现金及短期投资LHRNR
| Q1 26 | $981.1M | $1.6B | ||
| Q4 25 | $532.3M | $1.7B | ||
| Q3 25 | $598.1M | $1.7B | ||
| Q2 25 | $647.3M | $1.4B | ||
| Q1 25 | $369.4M | $1.6B | ||
| Q4 24 | $1.5B | $1.7B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $265.1M | $1.6B |
总债务LHRNR
| Q1 26 | $5.8B | — | ||
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $2.0B |
股东权益LHRNR
| Q1 26 | $8.7B | $4.3B | ||
| Q4 25 | $8.6B | $11.6B | ||
| Q3 25 | $8.7B | $11.5B | ||
| Q2 25 | $8.5B | $10.8B | ||
| Q1 25 | $8.3B | $10.3B | ||
| Q4 24 | $8.1B | $10.6B | ||
| Q3 24 | $8.2B | $11.2B | ||
| Q2 24 | $8.0B | $10.2B |
总资产LHRNR
| Q1 26 | $19.1B | $53.7B | ||
| Q4 25 | $18.4B | $53.8B | ||
| Q3 25 | $18.3B | $54.5B | ||
| Q2 25 | $18.1B | $54.7B | ||
| Q1 25 | $17.6B | $53.6B | ||
| Q4 24 | $18.4B | $50.7B | ||
| Q3 24 | $18.6B | $52.8B | ||
| Q2 24 | $16.7B | $51.6B |
负债/权益比LHRNR
| Q1 26 | 0.67× | — | ||
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.21× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.17× | ||
| Q2 24 | — | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $191.5M | — |
| 自由现金流经营现金流 - 资本支出 | $70.5M | — |
| 自由现金流率自由现金流/营收 | 2.0% | — |
| 资本支出强度资本支出/营收 | 3.4% | — |
| 现金转化率经营现金流/净利润 | 0.69× | — |
| 过去12个月自由现金流最近4个季度 | $1.4B | — |
8季度趋势，按日历期对齐
经营现金流LHRNR
| Q1 26 | $191.5M | — | ||
| Q4 25 | $614.2M | $483.0M | ||
| Q3 25 | $387.2M | $1.6B | ||
| Q2 25 | $620.6M | $1.5B | ||
| Q1 25 | $18.5M | $157.8M | ||
| Q4 24 | $777.2M | $778.9M | ||
| Q3 24 | $277.3M | $1.5B | ||
| Q2 24 | $561.1M | $1.2B |
自由现金流LHRNR
| Q1 26 | $70.5M | — | ||
| Q4 25 | $490.3M | — | ||
| Q3 25 | $280.5M | — | ||
| Q2 25 | $542.7M | — | ||
| Q1 25 | $-107.5M | — | ||
| Q4 24 | $665.1M | — | ||
| Q3 24 | $161.5M | — | ||
| Q2 24 | $432.9M | — |
自由现金流率LHRNR
| Q1 26 | 2.0% | — | ||
| Q4 25 | 13.9% | — | ||
| Q3 25 | 7.9% | — | ||
| Q2 25 | 15.4% | — | ||
| Q1 25 | -3.2% | — | ||
| Q4 24 | 20.0% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 13.4% | — |
资本支出强度LHRNR
| Q1 26 | 3.4% | — | ||
| Q4 25 | 3.5% | — | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 3.8% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 3.5% | — | ||
| Q2 24 | 4.0% | — |
现金转化率LHRNR
| Q1 26 | 0.69× | — | ||
| Q4 25 | 3.73× | 0.64× | ||
| Q3 25 | 1.48× | 1.73× | ||
| Q2 25 | 2.61× | 1.76× | ||
| Q1 25 | 0.09× | 0.93× | ||
| Q4 24 | 5.42× | — | ||
| Q3 24 | 1.64× | 1.26× | ||
| Q2 24 | 2.73× | 2.41× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LH
| Revenues | $2.8B | 78% |
| Other | $775.5M | 22% |
RNR
暂无分部数据
